Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Yamaguchi

Showing results (1-10 of 310) with videos related to

Pageof 31
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2017
OverviewHiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 10, 2020
[Significance of detecting minimal/measurable residual disease utilizing genetic mutations in acute myeloid leukemia]Hiroki Yamaguchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 9, 2007
[JAK2 gene mutation in chronic myeloproliferative disorders]Hiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Acute myeloid leukemia]Hiroki Yamaguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 11, 2008
[Abnormality of telomere maintenance linked to bone marrow failures]Hiroki Yamaguchi
International Journal of Hematology|September 3, 2024
Advances in pathogenesis research and challenges in treatment development for acute myeloid leukemiaHiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 17, 2017
Gene mutations in acute myeloid leukemiaHiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 8, 2021
[Overview]Hiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Importance of gene mutation analysis as prognostic factor of acute myeloid leukemia]Hiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Evidence on chronic myeloproliferative neoplasms from landmark clinical trials]Hiroki Yamaguchi
Pageof 31

Showing results (1-10 of 310) with videos related to

Sort By:
Pageof 31
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2017
OverviewHiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 10, 2020
[Significance of detecting minimal/measurable residual disease utilizing genetic mutations in acute myeloid leukemia]Hiroki Yamaguchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 9, 2007
[JAK2 gene mutation in chronic myeloproliferative disorders]Hiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Acute myeloid leukemia]Hiroki Yamaguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 11, 2008
[Abnormality of telomere maintenance linked to bone marrow failures]Hiroki Yamaguchi
International Journal of Hematology|September 3, 2024
Advances in pathogenesis research and challenges in treatment development for acute myeloid leukemiaHiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 17, 2017
Gene mutations in acute myeloid leukemiaHiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 8, 2021
[Overview]Hiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Importance of gene mutation analysis as prognostic factor of acute myeloid leukemia]Hiroki Yamaguchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Evidence on chronic myeloproliferative neoplasms from landmark clinical trials]Hiroki Yamaguchi
Pageof 31